Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infantsParis, October 9, ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you ...

According to the CDC, 100,000 older adults a year end up in the hospital, and about 10,000 older adults die from RSV every ...

With this year’s respiratory illness season approaching, all babies who are residents of Ontario will soon be eligible for a free RSV shot. The provincial Ministry of Health has updated its ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

Sanofi to present data from Beyfortus to treat RSV diseases at IDWeek 2024 annual meeting: Paris Thursday, October 10, 2024, 12:00 Hrs [IST] Sanofi advances its ambition to protec ...

RSV has been found to make up a significant portion of cardiorespiratory hospitalizations, with older adults and infants most at risk for both hospitalizations and morbidity due to RSV.